Share on LinkedInShare on LinkedIn

ARTICLE · 09 OCTOBER 2009

Clinical Trial Liability Insurance Requirements In Turkey

Gün + Partners
Gün + Partners
Contributor
Gün + Partners

Gün + Partners

We are one of the oldest and largest law firms in Turkey and are considered internationally to be...

View firm profile
Explore more from Gün + Partners

Bureaucratic burden and uncertainties caused by lack of sufficient and relevant regulation were blamed by the pharmaceutical industry as one of the significant reasons for the relatively low number of clinical trials conducted in Turkey despite its potential in terms of population, qualified personnel and geographical location.

TurkeyInsurance

Bureaucratic burden and uncertainties caused by lack of sufficient and relevant regulation were blamed by the pharmaceutical industry as one of the significant reasons for the relatively low number of clinical trials conducted in Turkey despite its potential in terms of population, qualified personnel and geographical location.

The amount of investment in clinical trials in Turkey is expected to significantly rise in the near future due to willingness of the government as well as pharmaceutical companies for more investment in that area. Despite uncertainties the number of clinical trials conducted by innovative pharmaceutical companies is reported to have risen by 30 to 40 percent in 2008.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from